
Institutes
Institute of Experimental Neurology


The Institute of Experimental Neurology (INSPE) constitutes one of the major European institutes primarily dedicated to translational research in the neuroscience field. The overall ambition is to conjugate high level of basic research with the specific competences in pre-clinical and clinical research.
Organization
INSPE includes both research laboratories and the Neurological Department of Ospedale San Raffaele. The INSPE laboratories spans on four different levels in DIBIT2 buildings. View all the research units here.
The first floor is dedicated to neuropathology, experimental neurophysiology, neurogenetics of monogenic and complex diseases. The second floor is dedicated to basic and clinical neuroimmunology, neurobiology, neural stem cell research and neuroembriology. The third floor is focused on neuroimaging of neuroinflammatory and neurodegenerative disorders. The fourth floor includes labs on experimental imaging and molecular biology. Other laboratories involved in behavioral research, in signals that regulate myelination, in clinical neurophysiology and in the study of the effects of magnetic stimulation of the brain complete the research area.
Research
Inflammatory and neurodegenerative disorders of the central and peripheral nervous system, stroke, spinal cord nerve and traumatic injures represents the primary targets of the INSPE research. Our goal is to better understand the molecular mechanisms that sustain inflammatory and degenerative pathogenic mechanisms underlying neurological disorders so to identify therapeutic targets, validate in co-operation with pharma companies new treatments, develop new disease biomarkers for both clinical trials and patients monitoring. The molecular and functional bases for central and peripheral nervous system recovery processes and the potential to modulate them by cellular and gene therapy and by specific rehabilitation interventions are another area of interest of INSPE.
The neurological department is deeply involved in the definition of new treatment algorithms for stroke, inflammatory and neurodegenerative diseases.
Federica Agosta
Group leader, Neuroimaging of neurodegenerative diseases Unit
Alessandra Bolino
Group leader, Human inherited neuropathies Unit
Ubaldo Del Carro
Senior physician, Movement disorders Unit
Federica Esposito
Group leader, Human genetics of neurological diseases
Cinthia Farina
Group leader, Immunobiology of neurological disorders Unit
Raffaella Fazio
Group leader, Peripheral neuropathies Unit
Massimo Filippi
Group leader, Neuroimaging research Unit
Roberto Furlan
Group leader, Clinical neuroimmunology Unit
Letizia Leocani
Group leader, Experimental neurophysiology Unit
Giuseppe Magnani
Senior physician, Memory disorders Unit
Vittorio Martinelli
Senior physician, Inflammatory central nervous system disorders Unit
Gianvito Martino
Group leader, Neuroimmunology Unit
Fabio Minicucci
Group leader, Paroxysmal events Unit
Stefano Carlo Previtali
Group leader, Neuromuscolar repair Unit
Maria Assunta Rocca
Group leader, Neuroimaging of CNS white matter Unit
Angelo Quattrini
Group leader, Experimental neuropathology Unit
Carla Taveggia
Group leader, Axo-glia interaction Unit
Position available in Bioinformatics between the Institute of Experimental Nurology and the Center for Omics Sciences
Two fellowship positions are immediately available in the Axo-Glialinteraction Unit to work on perineurial invasion in pancreaticadenocarcinoma